CIK 0001889109 · Large accelerated filer
BELITE BIO, INC
Sign in to watch- Ticker
- BLTE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- other
- Phone
- 858-246-6240
- Business address
- 12750 HIGH BLUFF DRIVE SUITE 475, SAN DIEGO, CA, 92130
- Former names
- BELITE BIO, INC
- 6-K Event Report of Foreign Issuer
- 4 Other acquisition Chief Financial Officer acquired 5,000 shares (other)
- 4 Other acquisition Chief Executive Officer acquired 5,000 shares (other)
- 4 Option exercise Director acquired 13,796 shares (option exercise)
- 6-K Event Report of Foreign Issuer
- 4 Planned sale Chief Medical Officer sold 500 shares at an average $165.32 ($82,659)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Executive Officer sold 100,435 shares at an average $190.00 ($19,082,549)
- 4 Planned sale Chief Financial Officer sold 67,395 shares at an average $189.98 ($12,803,528)
- 6-K Event Report of Foreign Issuer
- 4 Planned sale Chief Financial Officer sold 367 shares at an average $180.35 ($66,187)
- 4 Planned sale Chief Executive Officer sold 365 shares at an average $180.35 ($65,827)
- 6-K Event Report of Foreign Issuer
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 6-K Event Report of Foreign Issuer
- 4 Open-market sale Chief Medical Officer sold 10,000 shares at an average $145.24 ($1,452,435)
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Medical Officer sold 10,000 shares at an average $140.57 ($1,405,729)
- 144 Insider Sale of Securities
Page 1 of 11 · 215 filings